NCT01568593View on ClinicalTrials.gov

Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome

PHASE3CompletedINTERVENTIONAL

Enrollment

93

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions

Dry Eye Syndromes

Interventions

DEVICE

T2750

1 drop in each eye 3 to 6 times daily during 84 days

DEVICE

Vismed

1 drop in each eye 3 to 6 times daily during 84 days

Trial Locations (1)

Unknown

Paris

Sponsors

Lead Sponsor

Laboratoires Thea

All Listed Sponsors

lead

Laboratoires Thea

INDUSTRY